Sun Valley Gold sells Vista Gold (VGZ) shares worth $2.16 million
Investing.com -- Inspira Technologies Oxy BHN Ltd (NASDAQ:IINN) stock climbed 6.3% in trading Thursday after the company announced it has completed the regulatory submission of its FDA-cleared INSPIRA ART100 system to the United Arab Emirates Ministry of Health and Prevention.
The life-support technology company expects final approval from UAE health authorities within days, which would mark a significant step toward commercial entry into the Gulf region. This regulatory milestone follows high-level government discussions in the UAE, where Inspira laid groundwork for potential nationwide deployment of its ART100 system.
"We are executing decisively on our global commercialization strategy for the ART100 system. The UAE’s regulatory progress marks a defining step forward in Inspira’s expansion across one of the world’s fastest-growing healthcare markets," said Dagi Ben-Noon, Chief Executive Officer of Inspira.
The company believes the anticipated authorization will strengthen its regional partnerships and open commercialization opportunities across UAE healthcare networks. Inspira Technologies describes itself as a pioneer in innovative life-support and diagnostic technologies.
The UAE is known for its efficient and innovation-driven regulatory framework, which could accelerate Inspira’s market entry timeline in the region.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.